China Antimitotic Drug MMAF 745017-94-1,Antimitotic Drug MMAF 745017-94-1 Manufacturer Sign in | Join Now | Sitemap | Inquiry Basket(0)
customer feedback | Message
Products Show
Home > API > Antimitotic Drug MMAF 745017-94-1

Antimitotic Drug MMAF 745017-94-1

  • Product Name:  Antimitotic Drug MMAF 745017-94-1
  • Model NO.:  745017-94-1
  • Origin:  CHINA
  • Brand Name:  VOLSENCHEM
  • Delivery Time:  3 weeks
  • Minimum Order:  Gram
  • Supply Ability:  Lab stage
Product Details:  Antimitotic Drug MMAF 745017-94-1

Antineoplastic Agent MMAF Cas No. 745017-94-1

Thera. Category: Antineoplastic

Cas No.:745017-94-1

Synonyms: HM-297C-22;MonoMethyl auristatin E (MMAE);N-Methyl-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide;N-Methyl-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide Monomethyl;MonoMethyl auristatin E;MMAE;Vedotin;MonoMethyl auristatin E(MMAE, vedotin)


Molecular Formula:C39H65N5O8

Molecular Weight: 731.96

Purity: ≥99%

Packing: Export worthy packing

Material Safety Data Sheet: Available on request

Usage: Monomethyl auristatin F (MMAF) CAS 745017-94-1 is a synthetic antineoplastic agent.[1] It is part of some experimental anti-cancer antibody-drug conjugates such as vorsetuzumab mafodotin and SGN-CD19A. In International Nonproprietary Names for MMAF-antibody-conjugates, the name mafodotin refers to MMAF plus its attachment structure to the antibody.

Share to:
Home | Product Show Room | Download | News | Company Profile | Contact Us | Sitemap | Link| Privacy Policy
Copyright © Taizhou Volsen Chemical Co., Ltd. All rights reserved..
Internet Marketing By Netcec& Bossgoo